PubMed HealthSearch

PubMed · 7576549

Optimal dynamic experiments for bioreactor model discrimination.

Abstract

This paper describes a general approach for dynamic model discrimination for continuous cultures and presents dynamic models for pure cultures of E. coli and C. utilis obtained using the method. For each pure culture system, four candidate models representing various levels of structure were considered. All models reduce to Monod growth kinetics at steady state. An optimized set of multivariable step inputs in selected manipulative variables was used to discriminate between candidate models. The models that best predicted the dynamic behavior were selected by comparison of model predictions with experimental data. Two discrimination functions were compared in terms of their ability to determine the optimal set of multivariable step inputs to discriminate between candidate models. Results indicate that model discrimination based on maximizing the minimum absolute difference between any two models for a given set of inputs possessed good potential for discrimination between candidate models. Models selected for E. coli and C. utilis from the model discrimination work are presented and compared with experimental data.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M J Cooney, K A McDonald. 1995. Optimal dynamic experiments for bioreactor model discrimination.. https://doi.org/10.1007/bf02431915

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Metabolic engineering of Candida yeasts for biotechnological applications.

Candida yeasts represent a versatile yet underexploited platform for industrial biotechnology. These yeasts utilize a remarkably broad range of carbon sources, particularly for hydrophobic carbon sources, coupled with robust growth and diverse biosynthetic capacities, making them promising hosts for sustainable production of chemicals, fuels, and proteins. Despite these advantages, industrial deployment of Candida species has been hindered by concerns regarding opportunistic pathogenicity and the historical lack of efficient genetic manipulation tools, leading to a substantial gap between metabolic potential and practical utilization. Recent advances in functional genomics, genome editing, and systems metabolic engineering are rapidly overcoming these barriers, enabling more precise and efficient strain development. In this review, we systematically summarize recent progress in the metabolic engineering of Candida species as microbial cell factories, with particular emphasis on expanding genetic toolkits, utilizting renewable and non-conventional carbon sources, and biosynthesizing high-value compounds. In addition, we propose a biosafety-oriented classification framework to support their safe industrial deployment. Finally, we discuss current challenges and emerging opportunities, emphasizing that the synergy of synthetic biology and artificial intelligence-driven design holds the key to unlocking the biotechnological potential of Candida yeasts.

Candida

Stress proteins and stress tolerance in an Antarctic, psychrophilic yeast, Candida psychrophila.

Conditions are described for the heat shock acquisition of thermotolerance, peroxide tolerance and synthesis of heat shock proteins (hsps) in the Antarctic, psychrophilic yeast Candida psychrophila. Cells grown at 15 degrees C and heat shocked at 25 degrees C (3 h) acquired tolerance to heat (35 degrees C) and hydrogen peroxide (100 mM). Novel heat shock inducible proteins at 80 and 110 kDa were observed as well as the presence of hsp 90, 70 and 60. The latter hsps were not significantly heat shock inducible. The absence of hsp 104 was intriguing and it was speculated that the 110 kDa protein may play a role in stress tolerance in psychrophilic yeasts, similar to that of hsp 104 in mesophilic species.

Candida

Candida-related changes and ASCUS: a potential trap!

Detection of potential pitfalls for the ASCUS interpretation is essential for appropriate patient management. Between 1991-1994, 50 cervicovaginal specimens with Candida spp. were submitted for pathologists' review because of a possible ASCUS diagnosis. None had been preceded by abnormal smears, and all were followed by one or more benign smears and/or biopsy. Candida-associated changes included nuclear enlargement with focal hyperchromasia and cytoplasmic changes of orangeophilia, vacuoles, and perinuclear rings. Initially, 16 cases had been interpreted as ASCUS and 34 as benign. Upon review, utilizing strict Bethesda System criteria for ASCUS and awareness of Candida-associated changes, 10 of the 16 ASCUS cases were reclassified as benign. Knowledge of Candida-associated changes which may mimic ASCUS can prevent overuse of the ASCUS term, providing optimal, cost-effective management.

Candida